Skip to Main Content
Don't have an account? Create Account
x
Don't have an account? Create Account

Statement on HHS General Counsel 340B Opinion

FOR IMMEDIATE RELEASE

Statement attributable to:
Beth Feldpush, DrPH
Senior Vice President of Policy and Advocacy
America’s Essential Hospitals

WASHINGTON — We thank the Department of Health and Human Services Office of the General Counsel for today’s strong statement rejecting the intolerable actions by drug companies to deny 340B Drug Pricing Program discounts to contract pharmacies.

The General Counsel states unequivocally what has been plainly evident to essential hospitals and other covered entities in the 340B program: The pharmaceutical industry has run afoul of the law that created 340B discounts and undermined the program’s benefits to the safety net.

We call on manufacturers to immediately restore 340B discounts to contract pharmacies and halt practices that have jeopardized access to lifesaving medications for millions of low-income people.

# # #

About America’s Essential Hospitals
America’s Essential Hospitals is the leading champion for hospitals and health systems dedicated to high-quality care for all, including the most vulnerable. We support our more than 300 members with advocacy, policy development, research, and education. Communities depend on essential hospitals to provide specialized, lifesaving services; train the health care workforce; advance public health and health equity; and coordinate care. Essential hospitals innovate and adapt to lead the way to more effective and efficient care. Learn more at essentialhospitals.org.

Contact:
Carl Graziano
cgraziano@essentialhospitals.org
202.585.0102

Share

About the Author

Graziano is senior director of communications for America's Essential Hospitals.

Previous Next
Close
Test Caption
Test Description goes like this